A vaccine approach to healthy lipoprotein levels.
Fricker
J
J
D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000906:Antibodies / Q000737:chemistry; D001161:Arteriosclerosis / Q000517:prevention & control*; D002352:Carrier Proteins / Q000235:genetics / Q000276:immunology*; D053480:Cholesterol Ester Transfer Proteins; D002986:Clinical Trials as Topic; D006023:Glycoproteins; D006801:Humans; D007564:Japan; D008075:Lipoproteins, HDL / Q000097:blood*; D008297:Male; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology; D011817:Rabbits; D014612:Vaccines / Q000008:administration & dosage / Q000138:chemical synthesis / Q000276:immunology*
D000906:Antibodies; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D006023:Glycoproteins; D008075:Lipoproteins, HDL; D010455:Peptides; D014612:Vaccines